Sinopharm Buys 57% of Winteam Pharma for $252 Million
Sinopharm, China’s giant state-owned pharmaceutical company, has closed the purchase of a 57% stake in Winteam Pharmaceutical Group Ltd.  Sinopharm paid about $252 million to make the acquisition. Winteam, whose headquarters are in Hong Kong, operates in mainland China. The company makes TCM preparations, western-style chemical drugs and biologics. The acquisition builds Sinopharm’s portfolio, especially in the area of TCM drugs. More details..... Stock Symbol: (HK: 0570) Share this with colleagues: // //  
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here